45 Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N, Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 1987; 82: 59-64.
46 Rice KL, Leatherman JW, Duane PG, Snyder LS, Harmon KR, Abel J, Niewoehner DE. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. Ann Intern Med 1987; 107: 305-9.
47 Callahan CM, Cittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991; 114: 216-23.
48 Keatings VM, Jatakanon A, Worsdell Y, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-8.
49 Culpitt SV, Maziak W, Loukidis S etal. Effects of high dose inhaled steroids on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1635-9.
50 Sachs APE, Koeter GH, Groenier KH, Van der Waaij D, Schiphuis J, Meyboom-de Jong B. Changes in symptoms, peak expiratory flow and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995; 50: 758-63.
51 Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A Meta-Anal JAMA 1995; 273: 957-60.
52 Moser KM, Luchsinger PC, Adamson JS, McMahon SM, Schlueter DP, Spivack M, Weg JG. Respiratory stimulation with intravenous doxapram in respiratory failure. N Engl J Med 1973; 288: 427-31.
53 Angus RM, Ahmed AA, Fenwick LJ, Peacock AJ. Comparison of the acute effects on gas exchange of nasal ventillation and doxapram in exacerbations of chronic obstructive pulmonary disease. Thorax 1996; 51: 1048-50.
54 Gravil JH, Al-Rawas OA, Cotton MM etal. Home treatment of exacerbations of COPD by an acute respiratory assessment service. Lancet 1998; 351: 1853-5.
55 Cotton MM, Bucknall CE, Dagg KD etal. Early discharge for patients with exacerbations of COPD. a randomised controlled trial. Thorax 2000; 55: 902-6.
56 Skwarska E, Cohen G, Skwarski KM etal. A randomised controlled trial of supported discharge in patients with exacerbations of COPD. Thorax 2000; 55: 907-12.
57 Davies L, Wilkinson M, Bonner S, Calverley PMA, Angus RM. Hospital at home versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000; 321: 1265-8.
58 Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and out patient visits, hospitalisation and mortality in elderly patients with chronic lung disease. Ann Intern Med 1999; 130: 397-403.
59 Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322: 1271-4.
60 Burge PS, Calverley PMA, Jones PW etal. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to sever chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297303.
61 Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998; 351: 773-80.
62 Jarad N, Wedzicha JA, Burge PS, Calverley PMA. An observational study of inhaled corticosteroid withdrawal in patients with stable chronic obstructive pulmonary disease. Respiratory Med 1999; 93: 161-6.
63 Mahler DA, Donohue JF, Barbee RA etal. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999; 115: 957-65.
64 Van Noord JA, de Munck DRAJ, Bantje ThA etal. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. Eur Resp J 2000; 15: 878-85.
65 Vincken W, van Noord JA, Greefhorst APM. Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium. Eur Respir J 2002; 19: 209-16.
66 Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive lung disease: results from the Lung Health Study. Am J Respir Crit Care Med 2001; 164: 358-64.
67 Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. The relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52.
Was this article helpful?
Do You Suffer From ASTHMA Chronic asthma is a paralyzing, suffocating and socially isolating condition that can cause anxiety that can trigger even more attacks. Before you know it you are caught in a vicious cycle Put an end to the dependence on inhalers, buying expensive prescription drugs and avoidance of allergenic situations and animals. Get control of your life again and Deal With Asthma Naturally